AUTUMN VIARS: Open Payments
NPI 1083469340 · MOUNT VERNON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$669 in 28 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $343 · 2025 $669
Food & beverage: $657Education: $12
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $267 |
| Neurocrine BioSciences, Inc. | 4 | $86 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| E.R. Squibb & Sons, L.L.C. | 3 | $57 |
| ABBVIE INC. | 2 | $50 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| Janssen Pharmaceuticals, Inc | 2 | $36 |
| Vanda Pharmaceuticals Inc. | 1 | $33 |
| Supernus Pharmaceuticals, Inc. | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
Products named: CAPLYTA, INGREZZA, COBENFY, VRAYLAR, Auvelity, REXULTI, SPRAVATO, FANAPT.
Industry payments across OH — which companies pay providers there.
